ANN

Kraig Biocraft Laboratories Signs Landmark Agreement in Vietnam's Silk Production Capital

Retrieved on: 
Monday, April 8, 2024
Dragon silk, ANN, News, KBLB, Memorandum, OTCQB, VSA, Pharmaceutical industry

ANN ARBOR, Mich., April 08, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today that it has signed a landmark agreement with the Vietnam Sericulture Association ("VSA").

Key Points: 
  • ANN ARBOR, Mich., April 08, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today that it has signed a landmark agreement with the Vietnam Sericulture Association ("VSA").
  • As part of this agreement, the Company disclosed its production plans and schedule for the next twenty-four months to the VSA to obtain cooperation in reaching its production targets.
  • This agreement establishes a collaborative working effort between the Company and the VSA, something the Company has been actively working towards for some time.
  • This landmark agreement establishes the framework and much of the logistical support needed for the Company to achieve metric-ton levels of production.

Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity

Retrieved on: 
Sunday, April 7, 2024
Uric acid, Urinary tract infection, Anaphylaxis, Myocardial infarction, Common, Bronchitis, Patient, Atherosclerosis, FAHA, Cleveland Clinic, Bempedoic acid, Ezetimibe, Therapy, Anemia, Pain, MACE, Sinusitis, ACC, FOMA, FNLA, FACC, Obesity, Cardiovascular disease, Esperion Therapeutics, Abdominal pain, Risk, Gout, Spasm, Woman, American College, Body mass index, ESPR, Back pain, Outcome, ATP, Safety, Fatigue, Arthralgia, ANN, Angioedema, Kidney, Journal, Constipation, University, Adverse event, Pregnancy, CLEAR, Rash, MPH, Rupture, FDA, Molina Healthcare, JACC, Hypersensitivity, Health, Circulatory system, Tablet, CVD, Incidence, Diarrhea, Fetus, Gallstone, Diet, Excipient, Upper respiratory tract infection, Dietary supplement

ANN ARBOR, Mich., April 07, 2024 (GLOBE NEWSWIRE) -- Esperion (Nasdaq: ESPR) today announced the presentation of results from three pre-specified subgroups from CLEAR Outcomes at the 2024 American College of Cardiology’s Annual Scientific Sessions (ACC.24): women, Hispanic/Latinx, and patients with obesity. These results align with the American College of Cardiology’s robust diversity, equity and inclusion programs to drive cultural change across the profession and ensure that the cardiovascular care team is as diverse as the patients they care for and that all patients are represented in cardiovascular research. The data also reinforce the mission of the ACC: transforming cardiovascular care for all.

Key Points: 
  • “Bempedoic acid is the only FDA approved non-statin LDL lowering therapy to demonstrate reductions in MACE in both primary prevention and secondary prevention patient populations.
  • The Hispanic population is the largest ethnic minority in the U.S., yet is a population historically underrepresented in clinical trials.
  • At Esperion, we discover, develop, and commercialize innovative medicines to help improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases.
  • CLEAR Outcomes is part of the CLEAR clinical research program for NEXLETOL® (bempedoic acid) Tablet and NEXLIZET® (bempedoic acid and ezetimibe) Tablet.

Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024

Retrieved on: 
Monday, April 1, 2024
Health, ANN, Risk, Patient, Esperies, ESPR, FDA, Food, Pharmaceutical industry

ANN ARBOR, Mich., April 01, 2024 (GLOBE NEWSWIRE) -- Esperion (Nasdaq: ESPR) today announced that Sheldon Koenig, President and CEO, will ring the Nasdaq Stock Market (Nasdaq) opening bell at 9:30 a.m.

Key Points: 
  • ANN ARBOR, Mich., April 01, 2024 (GLOBE NEWSWIRE) -- Esperion (Nasdaq: ESPR) today announced that Sheldon Koenig, President and CEO, will ring the Nasdaq Stock Market (Nasdaq) opening bell at 9:30 a.m.
  • ET today, April 1, 2024, to commemorate the U.S. Food and Drug Administration’s (FDA) recent approval of broad new labels for Esperion’s products.
  • “We are honored to ring the Nasdaq opening bell to celebrate a significant milestone for Esperion,” said Mr. Koenig.
  • At Esperion, we discover, develop, and commercialize innovative medicines to help improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases.

Evolving Digital Innovation: Qubic's Journey Toward True AI

Retrieved on: 
Thursday, March 28, 2024
ANN, Initial public offering, Brain, Intelligence, CFB, AI, ALGO, Strong AI, IPO, TPS, Computer, Heart, Miner, Cryptocurrency

Tallinn, Estonia, March 28, 2024 (GLOBE NEWSWIRE) -- Qubic embarks on a transformative journey to empower global innovation with the potential of True AI.

Key Points: 
  • Tallinn, Estonia, March 28, 2024 (GLOBE NEWSWIRE) -- Qubic embarks on a transformative journey to empower global innovation with the potential of True AI.
  • At the heart of Qubic's efforts is Aigarth, an advanced AI system that symbolizes the platform's goal to grant universal access to the most sophisticated AI capabilities available.
  • Aigarth analyzes data from AI miners to construct billions of neural networks, thereby mimicking the complexity of a human brain.
  • This remarkable capacity stands as a testament to Qubic's dedication to creating a high-performance computational AI network that acts as the foundational support for True AI development, providing swift, secure, and scalable solutions for AI integration.

Kraig Biocraft Laboratories Shares Industry Update on Recombinant Spider Silk from Waste Plastics

Retrieved on: 
Thursday, March 28, 2024
RPI, Dragon silk, ANN, A-DNA, Microorganism, Recycling, Pseudomonas, Microplastics, Polyethylene, Silk, Research, News, Bacteria, Food, Molecular biology, KBLB, Plastic, Rensselaer Polytechnic Institute, OTCQB

ANN ARBOR, Mich., March 28, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), comments on an exciting advancement in spider silk engineering from the Rensselaer Polytechnic Institute ("RPI").

Key Points: 
  • ANN ARBOR, Mich., March 28, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), comments on an exciting advancement in spider silk engineering from the Rensselaer Polytechnic Institute ("RPI").
  • Researchers at RPI published a paper in Microbial Cell Factories outlining a new and novel method of creating spider silk protein from waste plastics.
  • Kraig Labs' recombinant spider silk production model utilizes traditional silk production systems involving planting mulberry trees to harvest and feed the leaves to silkworms.
  • The Company's specialized silkworms have been scientifically enhanced through molecular biology to create recombinant spider silk cocoons that are reeled to produce spider silk yarns and fabrics.

Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference

Retrieved on: 
Tuesday, March 26, 2024
Risk, Health, Patient, ANN, Conference, Esperies, ESPR, Broadcasting

ANN ARBOR, Mich., March 26, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced its participation in the 23rd Annual Needham Virtual Healthcare Conference.

Key Points: 
  • ANN ARBOR, Mich., March 26, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced its participation in the 23rd Annual Needham Virtual Healthcare Conference.
  • Sheldon Koenig, President and CEO, will participate in a fireside chat on Tuesday, April 9, 2024, at 12:45 PM ET.
  • The Esperion management team will also host investor meetings that same day.
  • A live audio webcast can be accessed on the investor and media section of the Esperion website .

The Coretec Group Releases March 2024 Shareholder Call Transcript and Webcast Recording

Retrieved on: 
Wednesday, March 20, 2024
CHS, EV, ANN, EVS, Webcast, Electronics, Research, Policy, Bank statement, Kappers, CCM, OTCQB, Marketing, Core, Silicon, Management

ANN ARBOR, Mich., March 20, 2024 (GLOBE NEWSWIRE) -- The Coretec Group (OTCQB: CRTG), developers of silicon anode active materials for lithium-ion batteries and cyclohexasilane (CHS) for electric vehicles (EVs), cleantech, and emerging tech applications today released the transcript and webcast recording from its March 14, 2024 shareholder update on the Company’s Investor Relations Website .

Key Points: 
  • ANN ARBOR, Mich., March 20, 2024 (GLOBE NEWSWIRE) -- The Coretec Group (OTCQB: CRTG), developers of silicon anode active materials for lithium-ion batteries and cyclohexasilane (CHS) for electric vehicles (EVs), cleantech, and emerging tech applications today released the transcript and webcast recording from its March 14, 2024 shareholder update on the Company’s Investor Relations Website .
  • Key customer interests, as The Coretec Group’s and Core Optics’ target market is the major automotive companies.
  • Using its CCM testing technology, Core Optics is developing battery testing equipment, which could accelerate Coretec’s commercialization of Endurion.
  • The development of The Coretec Group’s CSpace technology could see critical advancements through the utilization of Core Optics’ dedicated research and development group that continuously works to improve its photonics offerings.

Milvus 2.4 Unveils Game-Changing Features for Enhanced Vector Search

Retrieved on: 
Wednesday, March 20, 2024
Inverted index, ANN, Algorithm, GPU, Data analysis, BM25, Multi, Expression, Collection, NVIDIA, Metadata

A new feature of Milvus 2.4 is its Multi-vector support, offering an end-to-end infrastructure solution for multi-vector search and reranker functionalities.

Key Points: 
  • A new feature of Milvus 2.4 is its Multi-vector support, offering an end-to-end infrastructure solution for multi-vector search and reranker functionalities.
  • Milvus 2.4 introduces a Grouping Search operation to enhance resource efficiency and developer productivity by ensuring users receive relevant and meaningful search results.
  • Milvus 2.4 introduces sparse vector support, facilitating efficient ANN search over sparse embeddings generated by models like SPLADEv2 or statistical models like BM25.
  • This enhances the accuracy of text search using hybrid search methodologies, providing users with more nuanced and relevant search results.

Kinetica Delivers Real-Time Vector Similarity Search

Retrieved on: 
Wednesday, March 20, 2024
Cloud, Synthetic media, ANN, OLAP, Gen, Algorithm, GPU, SQL, General partnership, RAG, SAN, Motion, Anomaly, LLM, Architecture, RAFT, Acceleration, Index, Language, NVIDIA, ANSI, Generative, Weather, Cryptocurrency

SAN JOSE, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Kinetica, the real-time GPU-accelerated database for analytics and generative AI, today unveiled at NVIDIA GTC the industry’s only real-time vector similarity search engine that can ingest vector embeddings 5X faster than the previous market leader, based on the popular VectorDBBench benchmark. Under the hood Kinetica uses NVIDIA RAPIDS RAFT to harness the power of the GPU for vector similarity search. With Kinetica’s best-in-class combined data and query latency for vector embedding pipelines, large language models (LLM) can immediately augment their results with new information via embeddings as soon as they are generated, without delays at scale.

Key Points: 
  • Under the hood Kinetica uses NVIDIA RAPIDS RAFT to harness the power of the GPU for vector similarity search.
  • High performance vector similarity search at speed and scale - Kinetica vectorization enables vector similarity search (exact nearest neighbor) at speed and scale even without an index.
  • Hybrid vector search combines similarity search with time-series, spatial, graph & OLAP through SQL - Build more powerful Generative AI applications by combining vector similarity search with filters, joins, aggregations, etc.
  • “By taking advantage of NVIDIA RAPIDS vector search, Kinetica can offer higher throughput, lower latency and faster index builds for Gen AI applications.”
    Kinetica’s vector similarity search is now available in Kinetica 7.2 for users of Kinetica Cloud Dedicated, Developer Edition, and Kinetica Enterprise.

Kraig Biocraft Laboratories Brings Leading Sericulture Expert from India for Launch of Spring Production Trials

Retrieved on: 
Tuesday, March 19, 2024
Dragon silk, KBLB, ANN, OTCQB, Research, News, Breeding

ANN ARBOR, Mich., March 19, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), announces today that Dr. Nirmal Kumar, a globally recognized expert in sericulture, will join the Company’s Senior Management in Vietnam to supervise the start of the spring production trials and the launch of the BAM-1 hybrid.

Key Points: 
  • ANN ARBOR, Mich., March 19, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), announces today that Dr. Nirmal Kumar, a globally recognized expert in sericulture, will join the Company’s Senior Management in Vietnam to supervise the start of the spring production trials and the launch of the BAM-1 hybrid.
  • Dr. Nirmal Kumar gained recognition as a leading authority in the breeding and rearing of silkworms through his 37 years of work at the Central Sericulture Research & Training Institute ("CSRTI") in India.
  • He will also assist senior management in outlining the blueprints for the planned continued expansion of production capacity in Vietnam.
  • To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news